Drug Development

Listings
  • Pharmaceutical Validation Guidelines | 21 CFR Part 11 Compliance 2018

    Pharmaceutical Validation Guidelines | 21 CFR Part 11 Compliance 2018

    Drug Development Zurich, Switzerland ( Zurich, Switzerland) November 9, 2017 1695.00 Dollar US$

    Course "Validation and 21 CFR Part 11 Compliance of Computer Systems" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: Computer Systems Validation (CSV) also kn...

  • 2017 FDA Data Integrity for Computerized Systems Seminar by  GlobalCompliancePanel

    2017 FDA Data Integrity for Computerized Systems Seminar by GlobalCompliancePanel

    Drug Development Mumbai (India ) February 16, 2017 209.00 Dollar US$

    Overview: The Problem: We have all heard of Data Integrity but do you really understand what it is? Do you understand how 21 CFR 11 and Annex 11 fit into this picture? Specifically, can you answer questions on the following? • Evolution of 21 CFR Par...

  • Anti-CR2 (THB-5)-Mc-MMAF ADC

    Anti-CR2 (THB-5)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CR2 monoclonal antibody (THB-5) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the ce...

  • Anti-CR2 (THB-5)-Mc-VC-PABC-MMAE ADC

    Anti-CR2 (THB-5)-Mc-VC-PABC-MMAE ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CR2 monoclonal antibody (THB-5) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Withi...

  • Anti-CD79b (clone ch2F2)-SMCC-DM1 ADC

    Anti-CD79b (clone ch2F2)-SMCC-DM1 ADC

    Drug Development Shirley (New York) November 10, 2017 1.00 Dollar US$

    Anti-CD79b (clone ch2F2)-SMCC-DM1 ADC is comprised of an anti-CD79B monoclonal antibody (clone ch2F2) conjugated via a SMCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediat...

  • Anti-CXCR4 (ulocuplumab)-pAcF-MMAF ADC

    Anti-CXCR4 (ulocuplumab)-pAcF-MMAF ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CXCR4 monoclonal antibody (ulocuplumab) conjugated via a pAcF linker to a MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. W...

  • Anti-CD79b (clone hu2F2.D7)-SMCC-DM1 ADC

    Anti-CD79b (clone hu2F2.D7)-SMCC-DM1 ADC

    Drug Development Shirley (New York) November 10, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (clone hu2F2.D7) conjugated via a SMCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Wi...

  • Anti-CXCR4-PEG-S-4FB-dasatinib ADC

    Anti-CXCR4-PEG-S-4FB-dasatinib ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CXCR4 monoclonal antibody conjugated via a PEG-S-4FB linker to dasatinib. Dasatinib, also known as BMS-354825, is a cancer drug. It is an oral Bcr-Abl tyrosine kinase inhibitorand Src family tyrosine kinase in...

  • Anti-CD79b (clone hu2F2.D7)-BMPEO-DM1 ADC

    Anti-CD79b (clone hu2F2.D7)-BMPEO-DM1 ADC

    Drug Development Shirley (New York) November 10, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (clone hu2F2.D7) conjugated via a BMPEO linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. W...

  • Anti-DLL3 (clone SC16.15)-PBD dimers ADC

    Anti-DLL3 (clone SC16.15)-PBD dimers ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-DLL3 monoclonal antibody (clone SC16.15) conjugated via a linker to PBD dimers. The PBD dimers is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocyto...

  • Anti-CD79b (clone hu2F2.D7)-Mc-MMAF ADC

    Anti-CD79b (clone hu2F2.D7)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 10, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CD79B monoclonal antibody (clone hu2F2.D7) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Wi...

  • Anti-CXCR4-dasatinib ADC

    Anti-CXCR4-dasatinib ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-CXCR4 monoclonal antibody conjugated via a linker to dasatinib. Dasatinib, also known as BMS-354825, is a cancer drug. It is an oral Bcr-Abl tyrosine kinase inhibitorand Src family tyrosine kinase inhibitor ap...